Roberta O.
- Country
- Italy
- Department
- Scienze Salute Donna Bambino e Sanità Pubblica
Research Overview
- Phase 2/3 Study of BMN 333 Versus Vosoritide in Children With Achondroplasia
- Evaluation of SAR442501 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Pediatric Achondroplasia: A Phase 2, Open-Label, Dose Escalation Study
- Phase 3 Multicenter Double-Blind Randomized Placebo-Controlled Trial Evaluating Infigratinib Efficacy and Safety in Pediatric Achondroplasia Patients
Data & Insights
Has run more than one trial at 16 of 45 partner sites.
Specializations
Skeletal Growth Disorders
This investigator specializes in the treatment and research of skeletal dysplasias, with particular focus on genetic growth disorders affecting bone development and stature in pediatric populations.
- Achondroplasia Management
- Hypochondroplasia Treatment
- Osteochondrodysplasia Care
Their expertise extends to evaluating novel therapeutic approaches for skeletal growth disorders in children.
Pediatric Growth Medicine
The investigator focuses on pediatric growth optimization and the development of therapeutic interventions for children with genetic growth disorders.
- Growth Velocity Assessment
- Long-term Growth Monitoring
- Height Development Studies
Their work encompasses comprehensive evaluation of growth parameters in children with skeletal dysplasias.
Therapeutic Innovation
The investigator evaluates novel therapeutic agents for skeletal growth disorders, including both oral and subcutaneous treatment modalities.
- Growth Disorder Therapeutics
- Safety and Efficacy Studies
- Long-term Treatment Outcomes
Their research encompasses the assessment of innovative treatments for genetic growth conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.